Smart R&D Pathways and Export Competitiveness: A Comparative Analysis of Bangladesh and China's Pharmaceutical Industry
DOI:
https://doi.org/10.61424/rjbe.v4i3.955Keywords:
Pharmaceutical exports; Research and development (R&D); Innovation finance; Export competitiveness; Bangladesh; China; Sustainable economic growthAbstract
This study examines how smart research and development (R&D) financing can promote sustainable pharmaceutical export growth by comparing Bangladesh and China. Using descriptive statistical analysis and secondary data from 2020–2025, the study evaluates pharmaceutical exports, R&D expenditure, domestic credit to the private sector, and GDP growth. The findings show that China's strong performance is supported by sustained R&D investment, diversified financing mechanisms, and coordinated government policies that foster innovation and high-value pharmaceutical exports. In contrast, Bangladesh has achieved notable success in generic medicine production and export expansion but continues to face challenges, including low R&D investment, limited innovation financing, and weak industry–university collaboration. As Bangladesh prepares for post-LDC graduation, strengthening its innovation ecosystem through increased R&D funding, financial incentives, venture capital, and institutional reforms will be crucial for maintaining export competitiveness. The study concludes that adopting smart R&D financing strategies can help Bangladesh transition toward an innovation-driven pharmaceutical industry and achieve sustainable export growth.
References
Aghion, P., Bloom, N., Blundell, R., Griffith, R., & Howitt, P. (2005). Competition and innovation: An inverted-U relationship. The Quarterly Journal of Economics, 120(2), 701–728. https://doi.org/10.1093/qje/120.2.701
Bangladesh Institute of Development Studies. (n.d.). Bangladesh Development Studies. https://bids.org.bd/publications
China Chamber of Commerce for Import & Export of Medicines & Health Products. (2025). China pharmaceutical import and export performance report: First quarter 2025. https://www.cphi-china.cn/2025-q1-pharma-report/
China National Medical Products Administration. (n.d.). National Medical Products Administration. https://www.nmpa.gov.cn
Export Promotion Bureau of Bangladesh. (n.d.). Export statistics. https://epb.gov.bd
Helgi Library. (2025). Research and development expenditure (% of GDP): China. https://www.helgilibrary.com/indicators/rd-expenditures-as-of-gdp/china/
Hu, M. C., & Mathews, J. A. (2021). China's pharmaceutical innovation system: Institutional evolution and policy implications. Research Policy. https://www.sciencedirect.com/journal/research-policy
Levine, R. (2005). Finance and growth: Theory and evidence. In P. Aghion & S. N. Durlauf (Eds.), Handbook of Economic Growth (Vol. 1A, pp. 865–934). Elsevier. https://www.sciencedirect.com/science/article/pii/S1574068405010129
Mazzucato, M. (2018). The entrepreneurial state: Debunking public vs. private sector myths (Revised ed.). Penguin Books. https://www.ucl.ac.uk/bartlett/public-purpose/publications/2018/jan/entrepreneurial-state
Organisation for Economic Co-operation and Development. (2023). Pharmaceutical innovation and access to medicines. https://www.oecd.org/health/pharmaceutical-innovation.htm
Romer, P. M. (1990). Endogenous technological change. Journal of Political Economy, 98(5, Part 2), S71–S102. https://doi.org/10.1086/261725
Shanghai Stock Exchange. (n.d.). STAR Market. http://star.sse.com.cn
United Nations Conference on Trade and Development. (2021). Technology and Innovation Report 2021: Catching technological waves for sustainable development. United Nations. https://unctad.org/publication/technology-and-innovation-report
United Nations Conference on Trade and Development. (n.d.). Least developed countries (LDCs). https://unctad.org/topic/least-developed-countries
United Nations Industrial Development Organization. (n.d.). Pharmaceutical manufacturing and industrial development. https://www.unido.org
World Bank. (n.d.). Research and development expenditure (% of GDP) (Indicator GB.XPD.RSDV.GD.ZS). https://data.worldbank.org/indicator/GB.XPD.RSDV.GD.ZS
World Bank. (2023). World Integrated Trade Solution (WITS): China pharmaceutical exports (HS30). https://wits.worldbank.org/trade/comtrade/en/country/CHN/year/2023/tradeflow/Exports/partner/ALL/product/30
World Health Organization. (n.d.). Publications. https://www.who.int/publications
World Trade Organization. (n.d.). Trade-Related Aspects of Intellectual Property Rights (TRIPS). https://www.wto.org
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Deepto Chakraborty, Nirjona Mondal
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
